Pharmaceutical spending and German reunification: parity comes quickly to Berlin.
As the Berlin Wall fell and the population of the Federal Republic of Germany (FRG, West Germany) swelled by 25 percent with the addition of the former German Democratic Republic (GDR, East Germany), the health care system struggled to keep pace. This article examines drug outlays by the statutory sickness funds during the first 2 years of unified operations. It shows that providing equivalent coverage quickly led to equal rates of pharmaceutical consumption nationwide, while in Berlin the former East outdistanced the West by a considerable margin.
U.S. Public Health Service, Washington, DC 20201.
E M
EM
Katz
D016527:Drug Costs / Q000639:trends; D005859:Germany, East; D005860:Germany, West; D005102:Health Expenditures / Q000706:statistics & numerical data / Q000639:trends*; D006302:Health Services Research; D006801:Humans; D007231:Infant, Newborn; D007356:Insurance, Pharmaceutical Services / Q000706:statistics & numerical data*; D009313:National Health Programs / Q000191:economics*; D011056:Political Systems; D012959:Socioeconomic Factors; D013222:State Medicine / Q000191:economics